Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
The origin of tumor heterogeneity is poorly understood, yet it represents a major barrier to effective therapy. In melanoma and in melanocyte development, the microphthalmia-associated transcription factor (Mitf) controls survival, differentiation, proliferation, and migration/metastasis. The Brn-2...
Prif Awduron: | Goodall, J, Carreira, S, Denat, L, Kobi, D, Davidson, I, Nuciforo, P, Sturm, R, Larue, L, Goding, C |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2008
|
Eitemau Tebyg
-
The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes.
gan: Carreira, S, et al.
Cyhoeddwyd: (2000) -
The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
gan: Schepsky, A, et al.
Cyhoeddwyd: (2006) -
CBP/p300 as a co-factor for the Microphthalmia transcription factor.
gan: Sato, S, et al.
Cyhoeddwyd: (1997) -
Microphthalmia family of transcription factors associated renal cell carcinoma
gan: Ling Xie, et al.
Cyhoeddwyd: (2019-10-01) -
MD investigation on the binding of microphthalmia-associated transcription factor with DNA
gan: Xiang-Feng Wang, et al.
Cyhoeddwyd: (2022-03-01)